Search Results

Business

Nemysis Limited Announces a Strategic Alliance With Bruno Farmaceutici S.p.A.

Nemysis is pleased to announce that it has entered into a Strategic Alliance Agreement with Bruno Farmaceutici S.p.A. for the mutual advancement of the portfolio and sales of each company.

November 8, 2023

·

2 min read

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty.

February 19, 2024

·

8 min read

Press Releases

Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer

August 12, 2024

·

3 min read

Nemysis Limited Signs IHAT Sales and Marketing Agreement

Nemysis Ltd and Bruno Farmaceutici SpA are pleased to announce they have signed a non-exclusive sales and marketing agreement for IHAT, Nemysis’ innovative oral iron supplementation product.

July 5, 2023

·

2 min read

Deals

Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici

Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici.

March 22, 2023

·

6 min read

Deals

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. announced the completion of the acquisition of Amryt Pharma Plc, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.

April 12, 2023

·

3 min read

Deals

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.

January 8, 2023

·

12 min read

Business

Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech

Dompé today announced the appointment of Shannon K. Sullivan as Chief Commercial Officer (CCO), effective immediately.

October 10, 2023

·

3 min read

Business

Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications

Gossamer Bio, Inc. and Chiesi Farmaceutici S.p.A announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib.

May 6, 2024

·

9 min read

Business

Bruno Villetelle Joins Seqster Advisory Board

Bruno Villetelle, Global Head of Data and Digital in Novartis Global Drug Development, joins Seqster as they prepare for unprecedented growth and expansion.

February 15, 2022

·

2 min read